Table 1.
Name | OMIM | Mutations | Phenotype | Current Treatment | Therapeutic Perspectives | |
---|---|---|---|---|---|---|
Diamond–Blackfan anemia | 105650 | •RPS7 | •RPL10A | •Anemia | •Chronic transfusions | •Danazol |
•RPS10 | •RPL11 | •Growth retardation | •Steroids | •L-leucine | ||
•RPS17 | •RPL15 | •Other defects ~30–50% | or | •Sotatercept | ||
•RPS19 | •RPL18 | •Craniofacial | • Hematopoietic Stem Cell Transplantation (HSCT) |
•Trifluoperazine | ||
•RPS24 | •RPL19 | •Upper limb | •SMER28 | |||
•RPS26 | •RPL26 | •Heart malformations | •Eltrombopag | |||
•RPLP0 | •RPL34 | •Urinary system malformations | ||||
•RPL3 | •RPL35 | |||||
•RPL5 | •RPL35A | |||||
•RPL9 | •TSR2 | |||||
•RPL10 | ||||||
X-linked dyskeratosis congenita | 305000 | •DKC1 | •Skin pigmentation | •Chronic transfusions | •Eltrombopag | |
•Nail dystrophy | •HSCT | •Danazol | ||||
•Leucoplakia | •Regular examinations in | |||||
•Cytopenia | •Immunology | |||||
•Other defect >30% | •Dermatology | |||||
•Epiphora | •Neurology | |||||
•Learning difficulties/mental retardation | •Ophthalmology | |||||
•Pulmonary disease | •Otolaryngology | |||||
•Hyperhidrosis | •Dental | |||||
•Extensive dental carries/loss | •Cardiology | |||||
•Short stature | •Pulmonary | |||||
•Hair loss/grey hair or sparse eyelashes | ||||||
•Esophageal stricture | ||||||
•Hypogonadism/undescended testes | ||||||
•Urethral stricture/phimosis | ||||||
•Malignancy | ||||||
•Liver cirrhosis/adenoma | ||||||
•Abnormal bone trabeculation/osteoporosis | ||||||
Treacher Collins syndrome | 154500 | •Defects of craniofacial development | •Reconstructive surgery | •MG132 or Bortezomib | ||
•TCOF1 | •Conductive hearing loss | •Speech therapy | ||||
•POLR1C | •Palpebral fissures’ lateral downward sloping | |||||
•POLR1D | •Mandible hypoplasia | |||||
•Cleft palate | ||||||
Cartilage hair hypoplasia | 250250 | •RMRP | •Short stature | •Granulocyte Colony-Stimulating Factor (GCSF) |
•Recombinant growth hormone | |
•Hypoplastic hair | •HSCT | •XAV939 | ||||
•Ligamentous laxity | ||||||
•Defective immunity | ||||||
•Hypoplastic anemia | ||||||
•Neuronal dysplasia of the intestine | ||||||
Shwachman–Diamond syndrome | 260400 | •Neutropenia | •Chronic transfusions | •Transforming Growth Factor beta (TGF-β) |
||
•SBDS | •Anemia | •Androgens | •Ataluren | |||
•DNAJC21 | •Thrombocytopenia | •HSCT | ||||
•EFL1 | •Bone marrow hypoplasia | •Reconstructive surgery | ||||
•SRP54 | •Skeletal abnormalities | •Pancreatic enzymes | ||||
•Pancreatic defects | •Vitamin supplements | |||||
•Dietary advice and surveillance | ||||||
5q-syndrome | 153550 | •RPS14 | •Macrocytic anemia | •Red blood cell transfusions | •Cenersen | |
•Erythroid hypoplasia | •Recombinant erythropoietin | •L-leucine | ||||
•Hypolobated micromegakaryocytes | •Thalidomide | |||||
•Retinoids | ||||||
•Chemotherapy | ||||||
•Hypomethylating agents | ||||||
•Bone marrow transplantation | ||||||
North American Indian | 604901 | •UTP4 | •Natal transient jaundice | •Liver transplantation | ||
childhood cirrhosis | •Biliary cirrhosis | |||||
•Portal hypertension | ||||||
Isolated congenital asplenia | 271400 | •RPSA | •Absence of spleen | •Anti-infection and antibiotic prophylaxis | ||
•Vaccination | ||||||
•Pneumococcal | ||||||
•Haemophilus influenzae type b | ||||||
•Meningococcal | ||||||
•Influenza | ||||||
Neurodevelopmental disorders | •RPL10 | •POLR1A | •Neural tube defects | •Mental health medication | ||
•RPS3 | •ERCC6 | •Microcephaly | •Speech therapy | |||
•LAS1L | •CSB | •Autism | •Pediatrics | |||
•SMN1 | •ERCC8 | •Schizophrenia | •Educational help | |||
•EXOSC3 | •CSA | •Epilepsy | ||||
•UBTF | •Cerebral palsy/periventricular leukomalacia | |||||
Bowen–Conradi syndrome | 211180 | •EMG1 | •Psychomotor defects | |||
•Growth retardation | ||||||
•Microcephaly | ||||||
•Micrognathia | ||||||
•Congenital vertical talus |